You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-small cell lung carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Immune signature in serum associated to the metabolic signature
  • Meta-genomic signature of intestinal flora
  • La Tronche, Isère, France
    University Hospital, Grenoble
Jan 6, 2023

Stage IB Non-small Cell Lung Cancer

Completed
  • Stage IB Non-Small Cell Lung Carcinoma
    • Shanghai, China
      180 Fenglin Road
    Jul 29, 2023

    Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Self-administered survey at hospital
    • +2 more
    • (no location specified)
    Oct 3, 2023

    Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in

    Active, not recruiting
    • Stage IA Non-Small Cell Lung Carcinoma
    • +3 more
    • Computed Tomography Perfusion Imaging
    • +2 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 5, 2022

    NSCLC Trial in Xinxiang (CCCR-NK92 cells)

    Enrolling by invitation
    • Non-small Cell Lung Cancer
    • CCCR-NK92 cells
    • Xinxiang, Henan, China
      The first Affiliated Hospital of Xinxiang Medical University
    Aug 31, 2022

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    Non-Squamous Non-Small Cell Lung Carcinoma, Stage I NSCLC, Stage IA Non-Small Cell Lung Carcinoma Trial in Abington,

    Active, not recruiting
    • Non-Squamous Non-Small Cell Lung Carcinoma
    • +7 more
    • Nivolumab
    • +3 more
    • Abington, Pennsylvania
    • +1 more
    Sep 14, 2022

    QOL After SURGERY and ADJUVANT Treatment

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Quality of Life
    • Questionnaires
    • Salamanca, Spain
      Hospital Clínico Universitario
    Oct 30, 2023

    Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)

    Not yet recruiting
    • Lung Non-Small Cell Carcinoma
    • Stage IV Lung Cancer AJCC v8
    • Biospecimen Collection
    • +5 more
    • Duarte, California
    • +1 more
    Aug 24, 2023

    Observing Palliative Asymptomatic Centrally Located Advanced

    Active, not recruiting
    • Non-small Cell Lung Carcinoma
    • None: Questionnaire Study
    • Toronto, Ontario, Canada
      University Health Network, Princess Margaret Hospital
    Oct 6, 2022

    Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

    Completed
    Has Results
    • Non-small Cell Lung Carcinoma
    • Pembrolizumab
    • +7 more
    • (no location specified)
    Oct 13, 2022

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Non-Small-Cell Lung Carcinoma, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma Trial (Liquid biopsy)

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • +2 more
    • Liquid biopsy
    • (no location specified)
    Jan 24, 2023

    Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)

    Recruiting
    • Metastatic Non-small Cell Lung Cancer (NSCLC)
    • +5 more
    • data collection
    • Oldenburg, Germany
      Pius-Hospital
    Jul 20, 2022

    Non-small Cell Lung Carcinoma Trial (BPI-361175)

    Not yet recruiting
    • Non-small Cell Lung Carcinoma
    • (no location specified)
    Oct 18, 2022

    Metastatic Squamous Non-Small Cell Lung Carcinoma Trial in Chicago (Cabozantinib 40 MG, Pembrolizumab 200mg)

    Recruiting
    • Metastatic Squamous Non-Small Cell Lung Carcinoma
    • Cabozantinib 40 MG
    • Pembrolizumab 200mg
    • Chicago, Illinois
      University of Illinois at Chicago
    Jan 20, 2023

    Tabrecta® (Capmatinib) in South Korea

    Not yet recruiting
    • Non-Small-Cell Lung Carcinoma
    • Capmatinib
    • (no location specified)
    Jan 19, 2023

    NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • +3 more
    • Montanide (Registered Trademark) ISA-51 VG Adjuvant
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Stage I NSCLC AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7 Trial in

    Recruiting
    • Stage I Non-Small Cell Lung Cancer AJCC v7
    • +6 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    May 2, 2022

    Lung Cancer Trial (ortataxel)

    Completed
    • Lung Cancer
    • (no location specified)
    Sep 23, 2022

    NSCLC Trial in Melbourne, London (Pembrolizumab, Radiotherapy (SABR))

    Completed
    • Non-small Cell Lung Cancer
    • Melbourne, Victoria, Australia
    • +1 more
    May 23, 2022

    Lung Cancer Circulating Tumor Cells

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Sample
    • Nice, France
      CHU de Nice
    Dec 5, 2022

    Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)

    Recruiting
    • Non-small-cell Lung Carcinoma
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 11, 2023

    EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC Trial in Worldwide (Atezolizumab, Bevacizumab, Carboplatin)

    Active, not recruiting
    • EGFRmutant Stage IIIB/C or IV Non-squamous NSCLC
    • Großhansdorf, Germany
    • +17 more
    Jan 12, 2023

    Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Sacramento (Anti-PD-L1 Monoclonal Antibody MPDL3280A,

    Terminated
    • Recurrent Non-Small Cell Lung Carcinoma
    • Stage IV Non-Small Cell Lung Cancer
    • Anti-PD-L1 Monoclonal Antibody MPDL3280A
    • Stereotactic Body Radiation Therapy
    • Sacramento, California
      University of California Davis
    Aug 2, 2022